2013
DOI: 10.1016/j.bgm.2013.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Role of asparagine synthetase in doxorubicin-induced resistance

Abstract: Research has shown drug resistance as the major cause of failure of cancer chemotherapy. In this study, doxorubicin-sensitive human uterine cancer cell (hUCC) MES/SA, as well as doxorubicin-resistant hUCC MES/SA-DxR 2mM and MES/SA-DxR 8mM were used. Subsequently, asparagine synthetase (ASNS), a protein that had previously been proposed to be a putative cancer drug target in our laboratory, was silenced by siRNA knockdown to study the mechanism of doxorubicin-induced resistance further. After potent knockdown o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 6 publications
0
5
0
Order By: Relevance
“…Within the molecular pathways of DOX insensitivity or resistance, we identified for example high expression of Asns and Trib3 . Asns , encodes by asparagine synthetase, a protein known to induce DOX resistance in uterine cancer [ 30 ] and ALL [ 31 ] and has been proposed as a predictive biomarker for ovarian cancer and a therapeutic target for non‐Hodgkin's lymphoma. [ 32 ] Similarly, the pseudokinase TRIB3 expression is induced in response to cellular stress [ 33 ] and protects against the apoptotic effects of DOX in gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Within the molecular pathways of DOX insensitivity or resistance, we identified for example high expression of Asns and Trib3 . Asns , encodes by asparagine synthetase, a protein known to induce DOX resistance in uterine cancer [ 30 ] and ALL [ 31 ] and has been proposed as a predictive biomarker for ovarian cancer and a therapeutic target for non‐Hodgkin's lymphoma. [ 32 ] Similarly, the pseudokinase TRIB3 expression is induced in response to cellular stress [ 33 ] and protects against the apoptotic effects of DOX in gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…These examples illustrate the potential of ALTEN to identify the molecular pharmacological mechanisms and multidrug resistance, one of the current grand challenges of cancer therapy. [ 30 ]…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has now become clear that the activation of ER stress is a common phenomenon in tumorigenesis (Schewe et al 2008;Hazari et al 2016;Bi et al 2005). The altered expression of ER stress proteins has been observed in various cancer types, including lung cancer (Tsai et al 2013), breast cancer (Kim et al 2016), colon cancer (Ryan et al 2016), gastric cancer (Shen et al 2015), pancreatic cancer (Niu et al 2015), liver cancer (Shuda et al 2003;Al-Rawashdeh et al 2010), prostate cancer (Storm et al 2016;Liu et al 2017), kidney cancer (Fu et al 2010), skin cancer (Shimizu et al 2017), uterine cancer (Lin et al 2013), ovarian cancer (Cubillos-Ruiz et al 2015), leukemia (Buontempo et al 2016), myeloma (Zhong et al 2016), and gliobastoma (Epple et al 2013).…”
Section: Evidence Of Upr Involvement In Cancermentioning
confidence: 99%
“…It has now become clear that the activation of ER stress is a common phenomenon in tumourigenesis [80][81][82]. The altered expression of ER stress proteins has been observed in various cancer types, including lung [83], breast [84], colon [85], gastric [86], pancreatic [87], liver [88,89], prostate [90,91], kidney [37], skin [92], uterine [93], and ovarian cancers [94], leukaemia [95], myeloma [96] and glioblastoma [97].…”
Section: Er Stress Levels In Cancersmentioning
confidence: 99%